产品封面图

CFPAC-1

收藏
  • 询价
  • 2026年01月20日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 运输方式

      冻存运输

    • 器官来源

      胰腺

    • 库存

      大量

    • 生长状态

      贴壁生长

    • 相关疾病

      其他疾病

    • ATCC Number

      CRL-1918™

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 细胞形态

      上皮样

    • 年限

      26 years

    Designations: CFPAC-1
    Depositors:  RA Schoumacher
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: pancreas
    Disease: ductal adenocarcinoma; cystic fibrosis
    Derived from metastatic site: liver metastasis
    Cellular Products: carcinoembryonic antigen (CEA), 9 ng/ml; pancreatic oncofetal antigen (POA), 28 ng/ml; adenocarcinoma associated antigen (ACAA), 5000 ng/ml; CA 19-9 antigen, 12000 units/ml; epithelial keratins
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications: transfection host
    Tumorigenic: Yes
    Antigen Expression: CA19-9 antigen, 12000 units/ml
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 10
    D13S317: 12
    D16S539: 9,11
    D5S818: 10,11
    D7S820: 8,10
    THO1: 8
    TPOX: 8
    vWA: 17
    Cytogenetic Analysis: hyperdiploid; modal number = 73; range = 65 to 75; several translocations were evident; two to three apparently normal copies of number 7 (to which the cystic fibrosis gene has been mapped) were present in every metaphase examined
    Age: 26 years
    Gender: male
    Ethnicity: Caucasian
    Comments: This line was derived from a ductal adenocarcinoma (liver metastasis) from a patient with cystic fibrosis.
    The cells exhibit ion transport activities consistent with cystic fibrosis and express the product of the CF gene (cystic fibrosis transmembrane regulator, CFTR).
    CFPAC-1 cells show no effect of cAMP agonists, adenyl cyclase stimulators or phosphodiesterase inhibitors on Cl- flux, but do respond to Ca++ ionophores with increase Cl- efflux.
    The cells have the most common form of the CF mutation, deletion of three nucleotides resulting in the absence of phenylalanine at position 508.
    CFPAC-1 cells have epithelial morphology and polarization with apical microvilli, tight junctions and gap junctions.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:10 is recommended
    Medium Renewal: Every 2 to 3 days
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Doubling Time: 32 hrs
    References: 1785: Schoumacher RA, et al. A cystic fibrosis pancreatic adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 87: 4012-4016, 1990. PubMed: 1692630
    22227: McIntosh JC, et al. Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am. J. Med. 85: 592, 1988. PubMed: 3177424

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 中国科学院细胞库可供应细胞目录

      细胞  1000元 CFPAC-1  TCHu112  人  胰腺癌细胞  1000元 CGM1  GNHu 2  人  EB病毒转化的B细胞  450元 Chang liver  GNHu 9  人  张氏肝细胞  400元 CHL  GNHa 2  仓鼠  肺细胞  400元 CHO  GNHa 3  仓鼠  卵巢细胞  400元 CHO/dhFr-  GNHa 4  仓鼠  卵巢细胞,二氢叶酸还原酶缺陷  1000元 CHO-K1  GNHa 7  仓鼠  卵巢细胞亚株  800

    • 细胞名称大汇总

      -MES-1       肺鳞癌细胞 MDA-MB-435S       乳腺癌细胞        NCI-H661       大细胞肺癌细胞 ZR-75-1         乳腺癌细胞        NCI-H292       肺癌细胞(淋巴结转移) Hs 578T         乳腺癌细胞        U-937        组织细胞淋巴瘤细胞 CFPAC-1         胰腺癌细胞       A3 T        淋巴细胞白血病细胞 PANC-1         胰

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1620
    博辉生物科技(广州)有限公司
    2025年09月24日询价
    ¥1800
    上海酶研生物科技有限公司
    2026年01月04日询价
    ¥1280
    上海康朗生物科技有限公司
    2026年01月15日询价
    ¥680
    上海联迈生物工程有限公司
    2025年09月12日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月20日询价
    CFPAC-1
    询价